Newsroom: Latest News

22

Igyxos selected for the French Tech 120 (FT120) program for the third consecutive year

APR25

2022

21

Igyxos pursues its development and appoints Thierry Ziegler as CMC Chief Operating Officer

MAR15

2021

20

Igyxos and Selexis enter service agreement to advance Igyxos’ first-in-class monoclonal antibody for the treatment of human infertility

SEP02

2020

19

Igyxos raises €7.5 million to finance the preclinical and clinical development of its drug candidate First-In-Class in the treatment of human infertility

MAR21

2019